Breaking News Instant updates and real-time market news.

LUNA

Luna Innovations

$4.26

0.06 (1.43%)

, HSC

Harsco

$27.13

0.54 (2.03%)

09:07
06/27/19
06/27
09:07
06/27/19
09:07

Singular Research to hold a conference

Summer Solstice New York Summer Solstice 2019 Conference in New York on June 27 with webcasted presentations to begin at 9 am; not all presentations may be webcasted. Webcast Link

LUNA

Luna Innovations

$4.26

0.06 (1.43%)

HSC

Harsco

$27.13

0.54 (2.03%)

DAKT

Daktronics

$5.99

(0.00%)

ACU

Acme United

$21.20

-0.62 (-2.84%)

CMTL

Comtech

$28.00

0.52 (1.89%)

  • 27

    Jun

  • 12

    Sep

LUNA Luna Innovations
$4.26

0.06 (1.43%)

10/02/18
DAWS
10/02/18
INITIATION
Target $5.55
DAWS
Buy
Luna Innovations initiated with a Buy at Dawson James
Dawson James analyst Barry Sine initiated Luna Innovations with a Buy and $5.55 price target.
01/15/19
RILY
01/15/19
INITIATION
Target $4.6
RILY
Buy
Luna Innovations initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Dave Kang started Luna Innovations with a Buy rating and $4.60 price target. The analyst sees "catalyst-driven" sales growth and margin expansion for the company despite an uncertain macro backdrop.
01/15/19
01/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. StoneCo (STNE) initiated with a Buy at BofA/Merrill. 2. Southwest Gas (SWX) initiated with a Market Perform at Wells Fargo. 3. Luna Innovations (LUNA) initiated with a Buy at B. Riley FBR. 4. Dell Technologies (DELL) initiated with a Neutral at UBS. 5. Elanco (ELAN) initiated with a Buy at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/08/19
05/08/19
NO CHANGE

Luna Innovations reports Q1 EPS 3c, consensus 0c
Reports Q1 revenue $14.8M, consensus $13.0M. Reports Q1 adjusted EBITDA $1.0M vs. ($0.1M) last year.
HSC Harsco
$27.13

0.54 (2.03%)

08/03/18
LSCM
08/03/18
NO CHANGE
Target $31
LSCM
Buy
Harsco quarter the strongest in at least five years, says Lake Street
Lake Street analyst Robert Brown views Harsco's Q2 results and "excellent" and reiterates a Buy rating on the shares with a $31 price target. The Street is underappreciating the company's margin expansion opportunity and free cash flow potential, Brown tells investors in a post-earnings research note. He believes the Harsco's Q2 results were the strongest in at least five year as the company is seeing the results from its turnaround efforts and benefiting from a recovery in the industrial and rail end markets. The analyst now has increased confidence that Harsco can reach 13% operating margin at its long-term goal of $2B in revenue.
10/31/18
LSCM
10/31/18
NO CHANGE
LSCM
Harsco price target raised to $33 from $31 at Lake Street
Lake Street analyst Robert Brown reiterated a Buy rating on Harsco and raised his price target on shares to $33 from $31 following the company's "excellent" Q3 results. The analyst believes Harsco is seeing the results from its turnaround efforts and is benefitting from a recovery in the industrial and rail end markets, and is now shifting to growth mode, adding new contracts and expanding commercial efforts. Brown said the integration of the recent ALTEK acquisition is on track and he expects additional acquisitions in 2019.
02/21/19
LSCM
02/21/19
NO CHANGE
Target $33
LSCM
Buy
Harsco has opportunity to reach 'mid-$40's' if targets hit, says Lake Street
After Harsco management increased their long-term targets to $2.5B in revenue and $500M in EBITDA in 2021, up from $2B and $400M, Lake Street analyst Robert Brown attributed the guidance hike partially to an improving macro environment but also said it reflects results from the growth initiatives the company has undertaken. If the company can reach its 2021 targets, he estimates "a stock opportunity in the mid-$40's," said Brown, who keeps a Buy rating on Harsco shares with a $33 price target.
DAKT Daktronics
$5.99

(0.00%)

ACU Acme United
$21.20

-0.62 (-2.84%)

CMTL Comtech
$28.00

0.52 (1.89%)

09/28/18
BMOC
09/28/18
NO CHANGE
Target $40
BMOC
Outperform
Comtech price target raised to $40 from $37 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Comtech to $40 after its Q4 results, saying the quarter was "mostly positive" in spite of the top-line miss. The analyst points to better than expected earnings and gross margins along with new record highs in backlog, which adds to revenue visibility. Long added that the potential for Comtech to top $1B in sales "highlights strong demand" across its portfolio. The analyst anticipates the company's success in its products, including the "rapidly growing" Heights and BFT2 platforms, to continue into FY19.

TODAY'S FREE FLY STORIES

USB

U.S. Bancorp

$53.04

-0.07 (-0.13%)

07:24
07/17/19
07/17
07:24
07/17/19
07:24
Hot Stocks
U.S. Bancorp increases quarterly dividend 13.5% to 42c per share »

Based on the stress test…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

ALSN

Allison Transmission

$47.56

0.8 (1.71%)

07:23
07/17/19
07/17
07:23
07/17/19
07:23
Initiation
Allison Transmission initiated  »

Allison Transmission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

TCRR

TCR2 Therapeutics

$12.63

-0.14 (-1.10%)

07:22
07/17/19
07/17
07:22
07/17/19
07:22
Conference/Events
TCR2 Therapeutics management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 24

    Jul

LEA

Lear

$129.75

-5.33 (-3.95%)

07:22
07/17/19
07/17
07:22
07/17/19
07:22
Recommendations
Lear analyst commentary  »

Lear price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

HAS

Hasbro

$109.82

0.2 (0.18%)

07:21
07/17/19
07/17
07:21
07/17/19
07:21
Recommendations
Hasbro analyst commentary  »

Hasbro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CP

Canadian Pacific

$246.27

9.27 (3.91%)

07:20
07/17/19
07/17
07:20
07/17/19
07:20
Recommendations
Canadian Pacific analyst commentary  »

Canadian Pacific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PS

Pluralsight

$30.66

-0.71 (-2.26%)

07:20
07/17/19
07/17
07:20
07/17/19
07:20
Initiation
Pluralsight initiated  »

KeyBanc bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

07:20
07/17/19
07/17
07:20
07/17/19
07:20
Downgrade
CSX rating change  »

CSX downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 13

    Nov

07:20
07/17/19
07/17
07:20
07/17/19
07:20
General news
FX Update: EUR-USD edged out a fresh eight-day low »

FX Update: EUR-USD edged…

CTRP

Ctrip

$36.87

-0.48 (-1.29%)

07:19
07/17/19
07/17
07:19
07/17/19
07:19
Hot Stocks
Ctrip to upgrade Global SOS Emergency Response platform with UNDP »

Ctrip.com International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$94.00

2.7 (2.96%)

07:19
07/17/19
07/17
07:19
07/17/19
07:19
Recommendations
United Continental analyst commentary  »

United Continental target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

NVS

Novartis

$89.12

-0.2 (-0.22%)

07:18
07/17/19
07/17
07:18
07/17/19
07:18
Conference/Events
Novartis management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 22

    Jul

  • 23

    Jul

  • 25

    Sep

SCHW

Charles Schwab

$41.62

1.34 (3.33%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

IAC

IAC

$231.54

-2.55 (-1.09%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Hot Stocks
IAC to invest $250M in Turo car sharing marketplace »

IAC has agreed to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$38.60

-0.34 (-0.87%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Initiation
2U initiated  »

KeyBanc bullish on 2U,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.06

0.06 (0.32%)

07:15
07/17/19
07/17
07:15
07/17/19
07:15
Conference/Events
Alector management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 09

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:14
07/17/19
07/17
07:14
07/17/19
07:14
Hot Stocks
Vectura Group continues to seek partner for VR647 Phase III development »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Downgrade
Nu Skin rating change  »

Jefferies downgrades Nu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VEGPF

Vectura Group

$0.00

(0.00%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Hot Stocks
Vectura Group board approves capital return of approx. GBP50M »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

, GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Recommendations
Alphabet, Alphabet Class A, Facebook, Twitter analyst commentary  »

KeyBanc expects…

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

FB

Facebook

$203.87

-0.06 (-0.03%)

TWTR

Twitter

$38.00

-0.68 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 08

    Aug

  • 27

    Oct

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

07:12
07/17/19
07/17
07:12
07/17/19
07:12
Conference/Events
Cardiovascular Systems management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:11
07/17/19
07/17
07:11
07/17/19
07:11
Hot Stocks
Vectura Group confirms R&D investment priorities »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

07:10
07/17/19
07/17
07:10
07/17/19
07:10
Recommendations
Wells Fargo analyst commentary  »

Wells Fargo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

VMW

VMware

$172.25

0.03 (0.02%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Recommendations
VMware analyst commentary  »

VMware estimates likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

SMMT

Summit Therapeutics

$1.35

-0.06 (-4.26%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Hot Stocks
Summit presents preclinical data on SMT-571 at STI & HIV World Congress »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.